United States, New Hampshire — Portsmouth, New Hampshire

United States, New Hampshire is a clinical research site located in Portsmouth, New Hampshire, United States 03801.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

United States, New Hampshire has participated in 2 clinical trials.

Therapeutic areas: Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration.

Sponsors: Potentia Pharmaceuticals, Inc., Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, New Hampshire?

United States, New Hampshire has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, New Hampshire conducted?

United States, New Hampshire has 2 clinical trials on record. Their work covers Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration.

Is United States, New Hampshire accredited by Crixeo Health?

United States, New Hampshire has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, New Hampshire?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.